🔴 High ImpactCorporate
Honasa acquires 58% stake in Fluence Pharma
Honasa acquires 58% stake in Fluence Pharma to enter the nutraceuticals segment. This marks a strategic expansion beyond its core beauty and personal care business. The deal underscores growing consolidation in India’s wellness sector. Fluence Pharma’s portfolio includes science-backed dietary supplements and functional foods.
📊 STOCKS: HONASA | 🏢 SECTOR: Corporate | #HIGHIMPACT #M&A
#M&A#Nutraceuticals#HonasaConsumer
Stocks mentioned
⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.
Trade smarter on NSE
Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.
Start for ₹1 →